Upgrade to SI Premium - Free Trial

DiaMedica Therapeutics Inc. (DMAC)

5.64 -0.20 (3.42%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Form 4 DiaMedica Therapeutics For: Jun 01 Filed by: Giuffre Randall Michael June 3, 2026 5:28 PM - SEC Filing Form 4 DiaMedica Therapeutics For: Jun 01 Filed by: Kuntz Richard June 3, 2026 5:28 PM - SEC Filing Form 4 DiaMedica Therapeutics For: Jun 01 Filed by: O'Connor Daniel J. June 3, 2026 5:27 PM - SEC Filing Form 4 DiaMedica Therapeutics For: Jun 01 Filed by: Lewis Tanya June 3, 2026 5:27 PM - SEC Filing Form 4 DiaMedica Therapeutics For: Jun 01 Filed by: Semba Charles Pauling June 3, 2026 5:26 PM - SEC Filing Form 4 DiaMedica Therapeutics For: Jun 01 Filed by: Parsons James T. June 3, 2026 5:24 PM - SEC Filing Form 4 DiaMedica Therapeutics For: Jun 01 Filed by: Pauls Dietrich John June 3, 2026 5:24 PM - SEC Filing Form 4 DiaMedica Therapeutics For: Jun 01 Filed by: Kellen Scott June 3, 2026 5:23 PM - SEC Filing Form 4 DiaMedica Therapeutics For: Jun 01 Filed by: Krop Julie June 3, 2026 5:23 PM - SEC Filing DiaMedica Therapeutics to Present at the Jefferies Global Healthcare Conference 2026 May 27, 2026 4:30 PM - BizWire Form 8-K DiaMedica Therapeutics For: May 20 May 21, 2026 4:31 PM - SEC Filing DiaMedica reaches 75% enrollment milestone in stroke trial May 20, 2026 8:30 AM - StreetInsider DiaMedica Therapeutics Announces 75% Enrollment Milestone in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial May 20, 2026 8:30 AM - BizWire DiaMedica Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference May 12, 2026 4:15 PM - BizWire DiaMedica Therapeutics Inc. (DMAC) Reports In-Line Q1 EPS May 6, 2026 4:41 PM - StreetInsider Form 10-Q DiaMedica Therapeutics For: Mar 31 May 6, 2026 4:38 PM - SEC Filing Form 8-K DiaMedica Therapeutics For: May 06 May 6, 2026 4:37 PM - SEC Filing DiaMedica Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights May 6, 2026 4:30 PM - BizWire DiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026 April 30, 2026 8:25 AM - BizWire RedChip's Biotech Virtual Investor Conference Replays Now Available April 21, 2026 3:00 PM - StreetInsider RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms April 7, 2026 11:00 AM - StreetInsider Form ARS DiaMedica Therapeutics For: Dec 31 April 1, 2026 4:10 PM - SEC Filing Form DEFA14A DiaMedica Therapeutics April 1, 2026 4:09 PM - SEC Filing Form DEF 14A DiaMedica Therapeutics For: May 20 April 1, 2026 4:06 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on DiaMedica Therapeutics Inc. (DMAC) April 1, 2026 6:57 AM - StreetInsider Form 8-K DiaMedica Therapeutics For: Mar 30 March 31, 2026 6:08 AM - SEC Filing Form 10-K DiaMedica Therapeutics For: Dec 31 March 30, 2026 5:43 PM - SEC Filing DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights March 30, 2026 4:45 PM - BizWire DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026 March 23, 2026 8:25 AM - BizWire Full Article List